Rani Therapeutics Holdings (RANI) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Rani Therapeutics Holdings (RANI) over the last 5 years, with Q3 2025 value amounting to -$0.12.
- Rani Therapeutics Holdings' EPS (Weighted Average and Diluted) rose 5000.0% to -$0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.79, marking a year-over-year increase of 2547.17%. This contributed to the annual value of -$1987.1 for FY2024, which is 14930427.34% down from last year.
- Per Rani Therapeutics Holdings' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.12 for Q3 2025, which was up 5000.0% from -$0.18 recorded in Q2 2025.
- In the past 5 years, Rani Therapeutics Holdings' EPS (Weighted Average and Diluted) registered a high of $0.33 during Q3 2022, and its lowest value of -$552.11 during Q4 2024.
- Its 5-year average for EPS (Weighted Average and Diluted) is -$32.73, with a median of -$0.26 in 2024.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first skyrocketed by 30625.0% in 2022, then plummeted by 20438668.92% in 2024.
- Over the past 5 years, Rani Therapeutics Holdings' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.27 in 2021, then plummeted by 718.52% to -$2.21 in 2022, then surged by 87.78% to -$0.27 in 2023, then crashed by 204386.69% to -$552.11 in 2024, then soared by 99.98% to -$0.12 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.12 for Q3 2025, versus -$0.18 for Q2 2025 and -$0.22 for Q1 2025.